Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
about
In silico prediction of Gallibacterium anatis pan-immunogensVaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine developmentComplete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.Complete genome sequence of Salmonella enterica serovar Typhimurium LT2Prospects for vaccine prevention of meningococcal infectionMapping of the Neisseria meningitidis NadA cell-binding site: relevance of predicted {alpha}-helices in the NH2-terminal and dimeric coiled-coil regionsComparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesisNadA, a novel vaccine candidate of Neisseria meningitidisDiversity in coding tandem repeats in related Neisseria sppThe outer membrane protein Omp35 affects the reduction of Fe(III), nitrate, and fumarate by Shewanella oneidensis MR-1Bulked sample analysis in genetics, genomics and crop improvementMeningococcal serogroup B vaccine in Italy: state-of-art, organizational aspects and perspectivesCystoisospora suis - A Model of Mammalian CystoisosporosisStructural and Computational Biology in the Design of Immunogenic Vaccine AntigensMeningococcal B Vaccination (4CMenB) in Infants and ToddlersEmerging Vaccine TechnologiesGroup B Streptococcus vaccine: state of the artA maternal vaccine against group B Streptococcus: past, present, and futureAdvances in structure-based vaccine designLeishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral LeishmaniasisRole of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseOntology-supported research on vaccine efficacy, safety and integrative biological networksVaccines for the 21st centuryDesigning vaccines for the twenty-first century societyRole of ARF6, Rab11 and external Hsp90 in the trafficking and recycling of recombinant-soluble Neisseria meningitidis adhesin A (rNadA) in human epithelial cellsVaccines: the Fourth CenturySolution Structure of the Factor H-binding Protein, a Survival Factor and Protective Antigen of Neisseria meningitidisExploiting Antigenic Diversity for Vaccine Design: THE CHLAMYDIA ArtJ PARADIGMStructural Variations within the Transferrin Binding Site on Transferrin-binding Protein B, TbpBStructure of the C-terminal Domain of Neisseria Heparin Binding Antigen (NHBA), One of the Main Antigens of a Novel Vaccine against Neisseria meningitidisCrystal Structure of Outer Membrane Protein NMB0315 from Neisseria meningitidisStructure ofNeisseria meningitidislipoprotein GNA1162Crystal structure of c5321: a protective antigen present in uropathogenic Escherichia coli strains displaying an SLR foldReverse vaccinology 2.0: Human immunology instructs vaccine antigen designPrevention of rare diseases: how revolutionary techniques can help vulnerable individuals-the example of serogroup B meningococcal infectionDelivering vaccines to the people who need them mostProtein Crystallography in Vaccine Research and DevelopmentHealth and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programmeRapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motifThe key role of genomics in modern vaccine and drug design for emerging infectious diseases
P2860
Q21146619-3C250452-A845-4321-9C5E-68EF8DF351F0Q21328677-5B3185BE-E652-44E3-BE58-5FBE993E318EQ22066228-4FC83B54-1072-49D7-8032-061B7796C6C4Q22122369-25162111-AD40-4757-B952-3B2DFE6973FFQ24537338-8CFC048A-E213-4502-86A7-F7EE384CA455Q24600500-1C348001-82E8-428B-A3E4-81F6B21473D7Q24631126-E4C5943B-BA84-49ED-BD49-E01C7C29B9AFQ24675323-3FEBC4C5-A5D3-4570-8092-378384328633Q24801548-4B52B932-4F61-40A2-96B0-9728243A7376Q24804045-EA3DCF9B-EA6E-4921-9B5C-1E89371EF60FQ26753827-2BE77265-65CD-4B82-9C41-9DF2630854FCQ26770702-25ADC0E5-EDE1-4330-9ADD-B152C37F4C0CQ26776047-703A249C-7D43-49D7-AED3-7445BAE0B637Q26777382-015B5620-3627-44FB-A6BD-0380E0A4794FQ26782285-7711B175-5A02-47C4-9DE4-6240FD617DBAQ26783764-CFC9E664-77E4-4BE1-A7A6-C6C18718AFD1Q26796438-98FF1281-ABC9-4F7E-80C6-92EBB41619ABQ26822039-184AC72B-ADC4-4F9D-8E5A-C247D9E04DD9Q26824545-007B045B-2764-444D-8CDC-47981BC58361Q26858852-B7AD2F95-E514-46CB-B473-582CCDA0BF1EQ26995760-3DBEB54A-3683-4788-B70C-22D5145682DAQ27005991-BAE966F5-1D2C-4028-BC45-36C6930A6419Q27007529-CEF6E289-CCC1-4DAC-BF47-0D5A6E85FA46Q27025703-89DAF82E-8391-430D-A28C-EBD66D367D67Q27335545-D457ECED-FAFF-44CD-8E59-14374BA84596Q27490454-A9BBAC1E-758F-4B9A-B82D-EB504832C210Q27653667-43F266F4-BBB2-4A05-9B82-AB8E6289C450Q27662913-D8403440-8A7B-47F0-8800-535933D87FE9Q27666858-6EE571CC-29B4-4D48-8B28-91C1BFB5EA6BQ27674699-7630B76C-1046-42F9-9848-042B298D0193Q27675346-A43E2CCF-03BD-4E21-AB6B-C9B8742374FAQ27677157-6BCA91C0-CF85-4B47-ACE2-A2FCAE2DB1E3Q27680157-88D63587-017D-47F9-ABC9-ADE9AB42C532Q28075274-4E40180D-957A-4ED1-B418-41B1431FDB2CQ28080522-CAD36F3E-AEE2-4808-B221-592B1284C7E3Q28082744-67E548C1-57CA-4070-BEB0-69DCBF260A58Q28087528-5BD4F850-47A1-426F-B490-09856C80874DQ28391723-AB12C4DB-568B-439F-9F7B-36A55AB53862Q28469255-96CBC821-31D5-4D98-B0A7-F114A7A94738Q28476274-1283D260-6BB8-41A2-89DE-4A8402FA3974
P2860
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Identification of vaccine cand ...... us by whole-genome sequencing.
@ast
Identification of vaccine cand ...... us by whole-genome sequencing.
@en
type
label
Identification of vaccine cand ...... us by whole-genome sequencing.
@ast
Identification of vaccine cand ...... us by whole-genome sequencing.
@en
prefLabel
Identification of vaccine cand ...... us by whole-genome sequencing.
@ast
Identification of vaccine cand ...... us by whole-genome sequencing.
@en
P2093
P1433
P1476
Identification of vaccine cand ...... cus by whole-genome sequencing
@en
P2093
A C Jeffries
B Capecchi
C L Galeotti
D M Granoff
E Bartolini
P304
P356
10.1126/SCIENCE.287.5459.1816
P407
P577
2000-03-01T00:00:00Z